Hudson Bay Capital Management »

Intra Cellular Therapies shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 25k 71.62
2023-09-30 $1.8M 35k 52.09
2020-06-30 $513k 20k 25.65
2020-03-31 $2.0M 131k 15.37

More positions owned by Hudson Bay Capital Management

Amazon Call Option (AMZN)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Meta Platforms Cl A Put Option (META)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
NVIDIA Corporation Put Option (NVDA)
salesforce Put Option (CRM)
Select Sector Spdr Tr Financial (XLF)
Adobe Systems Incorporated Put Option (ADBE)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Intra Cellular Therapies

Vanguard Group
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Jpmorgan Chase & Co
Alliancebernstein
Franklin Resources
Wellington Management Company
Jennifer Ranahan
ClearBridge Advisors
Holocene Advisors
T. Rowe Price Associates
Norges Bank Investment Management
Charles Schwab Investment Management
Lord, Abbett & Co

View all funds holding Intra Cellular Therapies